China Gene Therapy Restores Hearing in 90% of Patients
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- China conducted a gene‑therapy trial for deafness that reported 90% of participants hearing significant improvement, per a Nature paper.
- Zheng‑Yi Chen noted that some patients can now hear whispers, indicating near‑normal auditory function after treatment.
- Mass Eye and Ear provided expertise, with Chen serving as otolaryngologist and co‑author of the study.
- Nature published the trial results, marking the first high‑profile peer‑reviewed evidence of this therapy’s efficacy.
Why it matters: Patients with genetic hearing loss gain functional hearing—90% of trial participants improved—while Chinese biotech firms attract new investment, accelerating gene‑therapy pipelines and strengthening China’s position in global pharma.
Ask SkimNews
